After a promising start, biotech IPOs all but fizzled out this year, but LB Pharmaceuticals is hoping that won't stymy its chances of completing a Nasdaq listing. New York-based LB is hoping to raise ...
Current political and economic issues succinctly explained. Sign up to receive CFR President Mike Froman’s analysis on the most important foreign policy story of the week, delivered to your inbox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback